Cancer detection and the community pharmacist

Area of Science:

• Oncology
• Pharmacy Practice
• Public Health

Background:

• Community pharmacists are accessible healthcare professionals.
• Patients often seek advice regarding potential cancer signs and symptoms from pharmacists.
• Pharmacists' current knowledge and confidence in recognizing diverse cancer symptomatology require evaluation.

Purpose of the Study:

• To assess community pharmacists' perceptions of their ability to recognize cancer signs and symptoms.
• To determine pharmacists' preferred methods for continuing education on cancer symptomatology.
• To evaluate the potential role of pharmacists in early cancer detection.

Main Methods:

• A questionnaire was distributed to 5,539 community pharmacists.
• 1,187 questionnaires were returned and analyzed.
• Data collected included patient interaction frequency, self-perceived recognition abilities, and educational preferences.

Main Results:

• 70% of pharmacists reported monthly patient inquiries about cancer symptoms.
• Nearly half noted patients attempting self-treatment for these symptoms.
• Pharmacists felt confident recognizing common cancers (skin, breast, colorectal) but not others.
• All pharmacists deemed cancer symptomatology education important, but lacked consensus on delivery format.

Conclusions:

• Community pharmacists are well-positioned to contribute to early cancer detection and prevention.
• Significant patient interaction regarding cancer symptoms highlights this potential.
• Further pharmacist education in cancer detection is warranted to improve patient outcomes.